Resources
Press Release, 21 December 2016
Kuros submits regulatory filing seeking CE certification for Neuroseal, a novel dural sealant
Press Release, 19 December 2016
Kuros to acquire Xpand in an all-share strategic transaction to create a leading commercial stage orthobiologics company
Press Release, 20 October 2016
Kuros Biosciences’ KUR-112 Receives Rare Pediatric Disease Designation
Press Release, 29 September 2016
Kuros Biosciences Reports Financial Results for First Half-Year of 2016
Press Release, 30 August 2016
Arbutus terminates license agreement for VLP platform for the treatment of hepatitis B infections
Press Release, 10 August 2016
Kuros appoints Philippe Saudan as Chief Development Officer